Developing story — details emerging. Check the source link for the latest updates.
Source: [Seeking Alpha](https://seekingalpha.com/article/4957287-protagonist-therapeutics-the-opt-out-that-turned-a-biotech-into-a-royalty-compounder?source=feed_all_articles)